| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
Enterobacter intermedius
|
0.03 |
0.5 |
≤0.008 － >16 |
Ertapenem (Invanz)  |
493 |
Enterobacter intermedius
|
0.03 |
0.5 |
0.03 － >4 |
Gatifloxacin (Tequin) |
412 |
Enterobacter intermedius
|
0.03 |
1 |
≤0.008 － >16 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
493 |
Enterobacter intermedius
|
0.06 |
0.5 |
0.016 － >4 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
412 |
Enterobacter intermedius
|
0.12 |
2 |
0.12 － >16 |
Cefepime (Maxipime) |
412 |
Enterobacter intermedius
|
>0.12 |
>16 |
0.12 － >16 |
Aztreonam (Azactam) |
412 |
Enterobacter intermedius
|
0.25 |
32 |
0.25 － >32 |
Ceftriaxone (Rocephin) |
412 |
Enterobacter intermedius
|
0.5 |
1 |
0.5 － >8 |
Imipenem |
412 |
Enterobacter intermedius
|
1 |
2 |
0.12 － >16 |
Imipenem |
493 |
Enterobacter intermedius
|
2 |
2 |
2 － >16 |
Gentamicin (Gentamycin, Garamycin) |
412 |
Enterobacter intermedius
|
2 |
4 |
0.25 － >32 |
Amikacin (Amikin) |
412 |
Enterobacter intermedius
|
>2 |
>16 |
2 － >16 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
412 |
Enterobacter intermedius
|
2 |
64 |
0.25 － 256 |
Zosyn |
412 |
Enterobacter intermedius
|
>32 |
>32 |
1 － >32 |
Amoxicillin-clavulanate |
493 |
Enterobacter intermedius
|
- |
- |
>16 － ? |
Cefpodoxime |
1481 |
Enterobacter intermedius
|
- |
- |
31.25 － ? |
Cefepime (Maxipime) |
348 |
Enterobacter intermedius
|
- |
- |
>64 － ? |
Aztreonam (Azactam) |
1481 |
Enterobacter intermedius
|
- |
- |
>64 － ? |
Cefotaxime (Cephotaxime, Claforan) |
1481 |
Enterobacter intermedius
|
- |
- |
>64 － ? |
Ceftriaxone (Rocephin) |
1481 |
Enterobacter intermedius
|
- |
- |
125 － ? |
Ziziphora persica (Essential oil) |
348 |
Enterobacter intermedius
|
- |
- |
128 － ? |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1481 |
Enterobacter intermedius
|
- |
- |
250 － ? |
Ziziphora persica (Methanol extract) |
348 |